Patents by Inventor Cheng-Jung Lai

Cheng-Jung Lai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Phosphoinositide 3-kinase inhibitors with a zinc binding moiety
    Patent number: 8367663
    Abstract: The instant application relates to deazapurines, thienopyrimidines and furopyrimidines with zinc-binding moiety based derivatives and their use in the treatment of phosphoinositide 3-kinase related diseases and disorders such as cancer. The instant application further relates to the the treatment of histone deacetylase related disorders and diseases related to both histone deacetylase and phosphoinositide 3-kinase.
    Type: Grant
    Filed: January 8, 2010
    Date of Patent: February 5, 2013
    Assignee: Curis, Inc.
    Inventors: Xiong Cai, Haixiao Zhai, Cheng-Jung Lai, Changgeng Qian
  • PHOSPHOINOSITIDE 3-KINASE INHIBITORS WITH A ZINC BINDING MOIETY
    Publication number: 20100222343
    Abstract: The instant application relates to deazapurines, thienopyrimidines and furopyrimidines with zinc-binding moiety based derivatives and their use in the treatment of phosphoinositide 3-kinase related diseases and disorders such as cancer. The instant application further relates to the the treatment of histone deacetylase related disorders and diseases related to both histone deacetylase and phosphoinositide 3-kinase.
    Type: Application
    Filed: January 8, 2010
    Publication date: September 2, 2010
    Inventors: Xiong Cai, Haixiao Zhai, Cheng-Jung Lai, Changgeng Qian
  • Stem cell-based methods for identifying and characterizing agents
    Publication number: 20050019801
    Abstract: The present invention provides methods of identifying and/or characterizing agents that promote differentiation of stem cells to a particular differentiated cell type. The invention further provides methods of treating injuries and degenerative diseases by administering agents that promote the differentiation of stem cells to particular differentiated cell types.
    Type: Application
    Filed: June 4, 2004
    Publication date: January 27, 2005
    Applicant: Curis, Inc.
    Inventors: Lee Rubin, Karen Kotkow, Cheng-Jung Lai